149 related articles for article (PubMed ID: 6959520)
1. Behavioral effects of haloperidol in young Tourette syndrome patients.
Bogomolny A; Erenberg G; Rothner AD
Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
[No Abstract] [Full Text] [Related]
2. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
Shapiro E; Shapiro AK
Adv Neurol; 1982; 35():413. PubMed ID: 6959518
[No Abstract] [Full Text] [Related]
3. Amantadine in Tourette syndrome.
Borison RL; Davis JM
Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
[No Abstract] [Full Text] [Related]
4. The pharmacotherapy of Tourette syndrome.
Caine ED
Int J Neurol; 1980; 14(1):123-6. PubMed ID: 6959970
[No Abstract] [Full Text] [Related]
5. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome.
Bruun RD
Adv Neurol; 1982; 35():433-6. PubMed ID: 6959521
[No Abstract] [Full Text] [Related]
6. Tourette's syndrome: an expanded view.
O'Quinn AN; Thompson RJ
Pediatrics; 1980 Sep; 66(3):420-4. PubMed ID: 6932642
[TBL] [Abstract][Full Text] [Related]
7. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
[TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia in Tourette syndrome.
Golden GS
Pediatr Neurol; 1985; 1(3):192-4. PubMed ID: 3880404
[TBL] [Abstract][Full Text] [Related]
9. New pharmacological approaches in the treatment of Tourette syndrome.
Borison RL; Ang L; Chang S; Dysken M; Comaty JE; Davis JM
Adv Neurol; 1982; 35():377-82. PubMed ID: 6756088
[No Abstract] [Full Text] [Related]
10. The natural history of Tourette syndrome: a follow-up study.
Erenberg G; Cruse RP; Rothner AD
Ann Neurol; 1987 Sep; 22(3):383-5. PubMed ID: 3479043
[TBL] [Abstract][Full Text] [Related]
11. Clozapine in tardive Tourette syndrome.
Jaffe E; Trémeau F; Sharif Z; Reider R
Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
[No Abstract] [Full Text] [Related]
12. [Treatment of Gilles de la Tourette Syndrome with haloperidol and clonidine].
Fennig S; Bauer A; Kronnenberg Y
Harefuah; 1984 May; 106(10):457-8. PubMed ID: 6590432
[No Abstract] [Full Text] [Related]
13. Treating Tourette syndrome with haloperidol: predictors of success.
Schwabe MJ; Konkol RJ
Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810
[TBL] [Abstract][Full Text] [Related]
14. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
Sallee FR; Dougherty D; Sethuraman G; Vrindavanam N
Biol Psychiatry; 1996 Nov; 40(10):1044-50. PubMed ID: 8915564
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol-induced dysphoria in patients with Tourette syndrome.
Caine ED; Polinsky RJ
Am J Psychiatry; 1979 Sep; 136(9):1216-7. PubMed ID: 289300
[No Abstract] [Full Text] [Related]
16. Effects of medications on regulation of body temperature of patients with Tourette syndrome.
Kessler AR
J Child Neurol; 2004 Mar; 19(3):220-4. PubMed ID: 15119484
[TBL] [Abstract][Full Text] [Related]
17. Clonidine treatment of Tourette syndrome.
Bruun RD
Adv Neurol; 1982; 35():403-5. PubMed ID: 6959516
[No Abstract] [Full Text] [Related]
18. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome.
Singer HS; Tune LE; Butler IJ; Zaczek R; Coyle JT
Adv Neurol; 1982; 35():177-83. PubMed ID: 6959488
[TBL] [Abstract][Full Text] [Related]
19. Tourette syndrome associated with mental retardation: a single-subject treatment study with haloperidol.
Rosenquist PB; Bodfish JW; Thompson R
Am J Ment Retard; 1997 Mar; 101(5):497-504. PubMed ID: 9083606
[TBL] [Abstract][Full Text] [Related]
20. Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent.
Caine ED; Margolin DI; Brown GL; Ebert MH
Am J Psychiatry; 1978 Feb; 135(2):241-3. PubMed ID: 272123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
